Two novel variations p.(Ser1275Thr) and p.(Ser1275Arg) in FLT4 causing prenatal hereditary lymphedema type 1.
FLT4 gene
Milroy disease
chylothorax
hydrops fetalis
lymphedema congenital type 1
Journal
Birth defects research
ISSN: 2472-1727
Titre abrégé: Birth Defects Res
Pays: United States
ID NLM: 101701004
Informations de publication
Date de publication:
15 03 2023
15 03 2023
Historique:
received:
22
11
2022
accepted:
08
12
2022
pubmed:
21
12
2022
medline:
8
3
2023
entrez:
20
12
2022
Statut:
ppublish
Résumé
Hereditary lymphedema 1 is a rare congenital condition, characterized by the development of chronic swelling in body parts. It is highly variable in expression and age of onset with different presentations: from feet edema to hydrops fetalis. This affection is genetically heterogeneous with autosomal dominant inheritance and incomplete penetrance due to a mutation in the FLT4 gene in most cases. In our study, we report on two fetuses harboring congenital lymphedema with FLT4 variation and review the prenatal confirmed ones of the literatures. Our cases were selected within fetuses explored by exome sequencing in a diagnosis setting. Prenatal ultrasonography showed hydrops fetalis in one case and an increased nuchal translucency with hydrothorax in the other. Comparative genomic hybridization array on amniocentesis was normal in both cases. Exome sequencing identified a variation p.(Ser1275Thr) and p.(Ser1275Arg) in fetus 1 and fetus 2 in the FLT4 gene, respectively. A de novo mutation at the same codon was reported in prenatal literature suggesting possible genotype phenotype correlation. Cystic hygroma/hydrops fetalis are possible manifestations of several disorders. This study illustrates how the integration of exome sequencing in prenatal clinical practice can facilitate the diagnosis and genetic counseling of heterogeneous developmental affections.
Sections du résumé
BACKGROUND
Hereditary lymphedema 1 is a rare congenital condition, characterized by the development of chronic swelling in body parts. It is highly variable in expression and age of onset with different presentations: from feet edema to hydrops fetalis. This affection is genetically heterogeneous with autosomal dominant inheritance and incomplete penetrance due to a mutation in the FLT4 gene in most cases.
CASES
In our study, we report on two fetuses harboring congenital lymphedema with FLT4 variation and review the prenatal confirmed ones of the literatures. Our cases were selected within fetuses explored by exome sequencing in a diagnosis setting. Prenatal ultrasonography showed hydrops fetalis in one case and an increased nuchal translucency with hydrothorax in the other. Comparative genomic hybridization array on amniocentesis was normal in both cases. Exome sequencing identified a variation p.(Ser1275Thr) and p.(Ser1275Arg) in fetus 1 and fetus 2 in the FLT4 gene, respectively. A de novo mutation at the same codon was reported in prenatal literature suggesting possible genotype phenotype correlation.
CONCLUSION
Cystic hygroma/hydrops fetalis are possible manifestations of several disorders. This study illustrates how the integration of exome sequencing in prenatal clinical practice can facilitate the diagnosis and genetic counseling of heterogeneous developmental affections.
Substances chimiques
FLT4 protein, human
EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-3
EC 2.7.10.1
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
563-571Informations de copyright
© 2022 The Authors. Birth Defects Research published by Wiley Periodicals LLC.
Références
Boudon, E., Levy, Y., Abossolo, T., Cartault, F., Brouillard, P., Vikkula, M., … Alessandri, J. L. (2015). Antenatal presentation of hereditary lymphedema type I. European Journal of Medical Genetics, 58(6), 329-331.
Brice, G., Child, A., Evans, A., Bell, R., Mansour, S., Burnand, K., … Mortimer, P. (2005). Milroy disease and the VEGFR-3 mutation phenotype. Journal of Medical Genetics, 42(2), 98-102.
Brouillard, P., Boon, L., & Vikkula, M. (2014). Genetics of lymphatic anomalies. The Journal of Clinical Investigation, 124(3), 898-904.
Connell, F. C., Ostergaard, P., Carver, C., Brice, G., Williams, N., Mansour, S., … Lymphoedema Consortium. (2009). Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Human Genetics, 124(6), 625-631.
Daniel-Spiegel, E., Ghalamkarpour, A., Spiegel, R., Weiner, E., Vikkula, M., Shalev, E., & Shalev, S. A. (2005). Hydrops fetalis: An unusual prenatal presentation of hereditary congenital lymphedema. Prenatal Diagnosis, 25(11), 1015-1018.
Dixelius, J., Mäkinen, T., Wirzenius, M., Karkkainen, M. J., Wernstedt, C., Alitalo, K., & Claesson-Welsh, L. (2003). Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. The Journal of Biological Chemistry, 278(42), 40973-40979.
Ferrell, R. E., & Pyeritz, R. E. (2013). Hereditary disorders of the lymphatic system and varicose veins. Emery and Rimoin's Principles and Practice of Medical Genetics (chapter 50). Emery and Rimoin's Principles and Practice of Medical Genetics, 12, 1-9.
Galland, F., Karamysheva, A., Pebusque, M. J., Borg, J. P., Rottapel, R., Dubreuil, P., … Birnbaum, D. (1993). The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene, 8(5), 1233-1240.
Gezginç, K., Yazıcı, F., & Gök, D. (2012). Prenatal diagnosis of Milroy's primary congenital lymphedema. Taiwanese Journal of Obstetrics & Gynecology, 51(2), 280-282.
Ghalamkarpour, A., Morlot, S., Raas-Rothschild, A., Utkus, A., Mulliken, J. B., Boon, L. M., & Vikkula, M. (2006). Hereditary lymphedema type I associated with VEGFR3 mutation: The first de novo case and atypical presentations. Clinical Genetics, 70(4), 330-335.
Gordon, K., Spiden, S. L., Connell, F. C., Brice, G., Cottrell, S., Short, J., … Ostergaard, P. (2013). FLT4/VEGFR3 and Milroy disease: Novel mutations, a review of published variants and database update. Human Mutation, 34(1), 23-31.
Holberg, C. J., Erickson, R. P., Bernas, M. J., Witte, M. H., Fultz, K. E., Andrade, M., & Witte, C. L. (2001). Segregation analyses and a genome-wide linkage search confirm genetic heterogeneity and suggest oligogenic inheritance in some Milroy congenital primary lymphedema families. American Journal of Medical Genetics, 98(4), 303-312.
Homsy, J., Zaidi, S., Shen, Y., Ware, J. S., Samocha, K. E., Karczewski, K. J., … Chung, W. K. (2015). De novo mutations in congenital heart disease with neurodevelopmental and other birth defects. Science, 350(6265), 1262-1266.
Jin, S. C., Homsy, J., Zaidi, S., Lu, Q., Morton, S., DePalma, S. R., … Brueckner, M. (2017). Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nature Genetics, 49(11), 1593-1601.
Levinson, K. L., Feingold, E., Ferrell, R. E., Glover, T. W., Traboulsi, E. I., & Finegold, D. N. (2003). Age of onset in hereditary lymphedema. The Journal of Pediatrics, 142(6), 704-708.
Lev-Sagie, A., Hamani, Y., Raas-Rothschild, A., Yagel, S., & Anteby, E. Y. (2003). Prenatal ultrasonographic diagnosis of atypical Nonne-Milroy lymphedema. Ultrasound in Obstetrics & Gynecology, 21(1), 72-74.
Makhoul, I. R., Sujov, P., Ghanem, N., & Bronshtein, M. (2002). Prenatal diagnosis of Milroy's primary congenital lymphedema. Prenatal Diagnosis, 22(9), 823-826.
Melikhan-Revzin, S., Kurolap, A., Dagan, E., Mory, A., & Gershoni-Baruch, R. (2015). A novel missense mutation in FLT4 causes autosomal recessive hereditary lymphedema. Lymphatic Research and Biology, 13(2), 107-111.
Mellor, R. H., Hubert, C. E., Stanton, A. W. B., Tate, N., Akhras, V., Smith, A., … Mortimer, P. S. (2010). Lymphatic dysfunction, not aplasia, underlies Milroy disease: Lymphatic dysfunction in Milroy disease. Microcirculation, 17(4), 281-296.
Milroy, W. F. (1892). An undescribed variety of hereditary oedema. Medizinhistorisches Journal, 56, 505-508.
Page, D. J., Miossec, M. J., Williams, S. G., Monaghan, R. M., Fotiou, E., Cordell, H. J., … Keavney, B. D. (2019). Whole exome sequencing reveals the major genetic contributors to non-syndromic tetralogy of Fallot. Circulation Research, 124(4), 553-563.
Reuter, M. S., Jobling, R., Chaturvedi, R. R., Manshaei, R., Costain, G., Heung, T., … Bassett, A. S. (2019). Haploinsufficiency of vascular endothelial growth factor related signaling genes is associated with tetralogy of Fallot. Genetics in Medicine, 21(4), 1001-1007.
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., … Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405-424.
Schneider, S., Köllges, R., Stegmann, J. D., Thieme, F., Hilger, A. C., Waffenschmidt, L., … Müller, A. (2022). Resequencing of VEGFR3 pathway genes implicate GJC2 and FLT4 in the formation of primary congenital chylothorax. American Journal of Medical Genetics Part A, 188(5), 1607-1611.
Sevim Bayrak, C., Zhang, P., Tristani-Firouzi, M., Gelb, B. D., & Itan, Y. (2020). De novo variants in exomes of congenital heart disease patients identify risk genes and pathways. Genome Medicine, 12, 9.
Sparks, T. N., Lianoglou, B. R., Adami, R. R., Pluym, I. D., Holliman, K., Duffy, J., … University of California, San Francisco Center for Maternal-Fetal Precision Medicine. (2020). Exome sequencing for prenatal diagnosis in nonimmune hydrops fetalis. The New England Journal of Medicine, 383(18), 1746-1756.
van Zanten, M., Mansour, S., Ostergaard, P., Mortimer, P., & Gordon, K. (1993). Milroy disease. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, G. Mirzaa, … A. Amemiya, et al. (Eds.), GeneReviews®. Seattle, WA: University of Washington, Seattle.
Vora, N. L., Gilmore, K., Brandt, A., Gustafson, C., Strande, N., Ramkissoon, L., … Powell, B. C. (2020). An approach to integrating exome sequencing for fetal structural anomalies into clinical practice. Genetics in Medicine, 22(5), 954-961.
Zhang, S., Chen, X., Yuan, L., Wang, S., Moli, D., Liu, S., & Wu, Y. (2019). Immunohistochemical evaluation of histological change in a Chinese Milroy disease family with venous and skin abnormities. Frontiers in Genetics, 10, 206.